Advertisement

Topics

Clinical Use of an Artificial Rectal Sphincter Device, Trade Name Fenix

2016-03-31 09:53:24 | BioPortfolio

Summary

This application is to obtain approval for clinical use of the Fenix, a Humanitarian Use Device. The Fenix device was just approved by the FDA as a Humanitarian Exempt Device for fecal incontinence. It has only been utilized in small numbers in Europe. There was a previous device produced by American Medical Systems, who sold their artificial bowel sphincter to Boston Scientific. Boston Scientific has elected to not continue the manufacturing of the artificial bowel sphincter. Investigators hope the Fenix will provide patients an alternative to colostomy.

Description

The Fenix is surgically placed either by a perineal approach or by laparoscopy. This surgery could be an outpatient procedure or at most an overnight stay in the hospital. The design of the device allows it to be effective immediately. The device is similar to the Lynx device used for esophageal reflux. It is a circular set of magnets which surrounds the rectum. The size of the device is determined at the time of surgery so that there is coaptation of the rectum when closed. When the patient strains at stool, this pressure separates the magnets and allows passage of stool. The magnets are held together my malleable metal ring. Once straining at stool stops, the magnets are able to re-connect or close the rectum.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Fecal Incontinence

Intervention

Artificial rectal sphincter for fecal incontinence

Location

Mayo Clinic in Florida
Jacksonville
Florida
United States
32224

Status

Recruiting

Source

Mayo Clinic

Results (where available)

View Results

Links

Published on BioPortfolio: 2016-03-31T09:53:24-0400

Clinical Trials [1136 Associated Clinical Trials listed on BioPortfolio]

A Placebo-Controlled Study of Clonidine for Fecal Incontinence.

Doctors at Mayo Clinic are doing a research study to assess the effects of a medication, clonidine, on fecal incontinence and rectal functions in women. Clonidine has been approved by the ...

Treatment of Patients With Fecal Incontinence

The purpose of this study is to determine if a behavioral treatment method called biofeedback will reduce the frequency of episodes of leakage of fecal material in patient suffering from f...

Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients

Fecal microbiome of donor and recipient will be analyzed before and after fecal microbiota transplantation in IBD patients.

Fecal Microbiota Transplantation for Ulcerative Colitis

Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. ...

Pilot Study of NASHA/Dx Gel for Fecal Incontinence

The study is an open, prospective, single-site study where 16 patients suffering from fecal incontinence will be included. Change in fecal incontinence episodes after intersphincteric inje...

PubMed Articles [2359 Associated PubMed Articles listed on BioPortfolio]

Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?

The fecal volatolome, which is composed of fecal volatile organic compounds (VOCs), seems to hold potential as non-invasive biomarker for the detection of colorectal cancer (CRC) and its precursor les...

Fecal Fat Concentration and Excretion in the First 2 Years of Life: a Cross-Sectional Study.

Data on pancreatic exocrine secretion in the youngest children are scarce. The aim of the study was to determine the range of normal values for fecal fat concentration (FFC) and fecal fat excretion (F...

Fecal source tracking based on fecal coliform concentration and bacterial community structure in the Bong stream, Korea.

Fecal source tracking of the Bong stream, a representative inland pollutant around the drainage basin of Gangjin Bay (an area where shellfish are grown for export), was performed three times in four c...

Development of a "ready to use" graphical tool based on artificial neural network classification: application for the prediction of late fecal incontinence after prostate cancer radiotherapy.

To apply artificial neural network (ANN) classification methods for the prediction of late fecal incontinence (LFI) following high-dose prostate cancer radiotherapy (RT) and to develop a "ready to use...

Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients with Chronic Functional Diarrhea.

Patients with bile acid diarrhea (BAD) are identified based on increased levels of BAs in fecal samples collected over a 48-hr period while on a 100-gram fat diet (48-hr BA), retention of Se-labeled h...

Medical and Biotech [MESH] Definitions

Abnormal descent of a pelvic organ resulting in the protrusion of the organ beyond its normal anatomical confines. Symptoms often include vaginal discomfort, DYSPAREUNIA; URINARY STRESS INCONTINENCE; and FECAL INCONTINENCE.

Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.

Surgical incision of the INTERNAL ANAL SPHINCTER typically in the treatment of FISSURE IN ANO; chronic ANAL FISSURE and FECAL INCONTINENCE.

Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. (From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65(2):209-12)

An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.

More From BioPortfolio on "Clinical Use of an Artificial Rectal Sphincter Device, Trade Name Fenix"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...


Searches Linking to this Trial